SIGN UP
LOG IN
N
NRSN
Neurosense Therapeutics Ltd
1.08
-0.72-40.00%After Hours: 1.115 +0.035 +3.24%19:51 08/01 EDT
OPEN/PREV CLOSE1.750/1.800
TODAY RANGE1.000-1.774
VOL1.59M
MARKET CAP25.91M
52 WEEK RANGE0.5985-2.600
AVG VOL (3M)339.32K
% TURNOVER6.61%
TURNOVER--
P/E (TTM)-1.9676
% RANGE43.01%
EPS(TTM)-0.5489
P/E(FORWARD)-2.3736
P/B9.71
BVPS0.1112
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP17.88M
SHARES OUTSTANDING23.99M
NEXT EARNINGS08/01-08/08
FREE FLOAT16.56M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·07/10 13:49
NeuroSense Therapeutics Releases Q2 2025 Corporate Update
Dow Jones·07/10 12:36
NeuroSense Therapeutics Is Maintained at Buy by D. Boral Capital
TipRanks·06/26 13:47
NeuroSense Completes Key Meeting with Health Canada for ALS Drug Approval
TipRanks·05/20 13:46
Maxim Group Reaffirms Their Hold Rating on Neurosense Therapeutics Ltd. (NRSN)
Benzinga·05/12 19:08
Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights
TipRanks·05/12 13:42
Target downgraded, Wayfair upgraded: Wall Street’s top analyst calls
Benzinga·05/12 13:20
This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
TipRanks·05/12 11:30
NeuroSense initiated with a Buy at D. Boral Capital
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.